DE60140211D1 - Verfahren um die resistenz gegen ein therapeutisches agenz vorherzusagen unter verwendung neuronaler netze - Google Patents

Verfahren um die resistenz gegen ein therapeutisches agenz vorherzusagen unter verwendung neuronaler netze

Info

Publication number
DE60140211D1
DE60140211D1 DE60140211T DE60140211T DE60140211D1 DE 60140211 D1 DE60140211 D1 DE 60140211D1 DE 60140211 T DE60140211 T DE 60140211T DE 60140211 T DE60140211 T DE 60140211T DE 60140211 D1 DE60140211 D1 DE 60140211D1
Authority
DE
Germany
Prior art keywords
resistance
disease
therapeutic
neural network
agency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140211T
Other languages
English (en)
Inventor
Brendan Larder
Dechao Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virco BVBA
Original Assignee
Virco BVBA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/589,167 external-priority patent/US7058616B1/en
Application filed by Virco BVBA filed Critical Virco BVBA
Application granted granted Critical
Publication of DE60140211D1 publication Critical patent/DE60140211D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
DE60140211T 2000-06-08 2001-06-01 Verfahren um die resistenz gegen ein therapeutisches agenz vorherzusagen unter verwendung neuronaler netze Expired - Lifetime DE60140211D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/589,167 US7058616B1 (en) 2000-06-08 2000-06-08 Method and system for predicting resistance of a disease to a therapeutic agent using a neural network
US24180100P 2000-10-20 2000-10-20
US24184400P 2000-10-20 2000-10-20
PCT/EP2001/006360 WO2001095230A2 (en) 2000-06-08 2001-06-01 Method for predicting therapeutic agent resistance using neural networks

Publications (1)

Publication Number Publication Date
DE60140211D1 true DE60140211D1 (de) 2009-11-26

Family

ID=27399520

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140211T Expired - Lifetime DE60140211D1 (de) 2000-06-08 2001-06-01 Verfahren um die resistenz gegen ein therapeutisches agenz vorherzusagen unter verwendung neuronaler netze

Country Status (9)

Country Link
US (1) US20030190603A1 (de)
EP (1) EP1352356B1 (de)
JP (1) JP4726177B2 (de)
AT (1) ATE445883T1 (de)
AU (1) AU785353B2 (de)
CA (1) CA2415832C (de)
DE (1) DE60140211D1 (de)
ES (1) ES2334011T3 (de)
WO (1) WO2001095230A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246859T3 (es) * 1999-05-28 2006-03-01 Virco Bvba Nuevos perfiles mutacionales en la transcriptasa inversa del vih-1 correlacionadas con una resistencia fenotipica a farmacos.
ES2321809T3 (es) * 2000-10-20 2009-06-12 Virco Bvba Establecimiento de valores e corte biologicos para predecir la resistencia a la terapia.
JP2004512032A (ja) * 2000-10-20 2004-04-22 ビルコ・ビーブイビーエイ 表現型薬物耐性と相互に関連付けられるｈｉｖ−１逆転写酵素中の新たな突然変異の特徴
FI20021031A (fi) * 2001-12-28 2003-06-29 Pertti Laehteenmaeki Ravintoautomaatti
FI20012593A0 (fi) * 2001-12-28 2001-12-28 Pertti Laehteenmaeki Menetelmä ja järjestelmä ravitsemustietopalvelun järjestämiseksi
US20050214744A1 (en) * 2002-07-01 2005-09-29 Hilde Azjin New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
EP1520247B1 (de) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutationsprofile bei mit phänotypischer medikamentenresistenz korrelierter hiv-1-protease
DE60321466D1 (de) * 2002-07-01 2008-07-17 Tibotec Pharm Ltd Mit phänotypischer medikamentenresistenz korrelierte mutationsprofile in hiv-1-reverse-transkriptase
US7194320B2 (en) * 2003-06-05 2007-03-20 Neuco, Inc. Method for implementing indirect controller
WO2005034736A2 (en) * 2003-10-10 2005-04-21 Biophysical Corporation Generation of biochemical images and methods of use
US20070197877A1 (en) * 2004-01-05 2007-08-23 Stefaan Decorte Behavior Based Multi-Agent Systems As Data Types
US8214271B2 (en) 2004-02-04 2012-07-03 Neuco, Inc. System and method for assigning credit to process inputs
JP5213228B2 (ja) 2004-03-02 2013-06-19 ビルコ・ビーブイビーエイ 臨床的カット−オフ値の推測
US7333861B2 (en) * 2004-10-25 2008-02-19 Neuco, Inc. Method and system for calculating marginal cost curves using plant control models
WO2007035719A2 (en) * 2005-09-19 2007-03-29 University Of Houston High throughput screening for antimicrobial dosing regimens
US20140011762A1 (en) * 2005-09-19 2014-01-09 Vincent H. Tam High Throughput Screening for Antimicrobial Dosing Regimens
SG10201505644PA (en) * 2010-07-28 2015-09-29 Herbminers Informatics Ltd Artificial intelligence and methods for relating herbal ingredients with illnesses in traditional chinese medicine
US8918352B2 (en) * 2011-05-23 2014-12-23 Microsoft Corporation Learning processes for single hidden layer neural networks with linear output units
US9336483B1 (en) * 2015-04-03 2016-05-10 Pearson Education, Inc. Dynamically updated neural network structures for content distribution networks
US10762982B1 (en) * 2015-10-07 2020-09-01 Trace Genomics, Inc. System and method for nucleotide analysis
US10629291B2 (en) * 2016-03-10 2020-04-21 Koninklijke Philips N.V. Antibiotic resistance causation identification
WO2018096153A1 (en) * 2016-11-28 2018-05-31 Koninklijke Philips N.V. Analytic prediction of antibiotic susceptibility
CN106640066B (zh) * 2016-12-28 2019-08-30 贵州大学 一种确定薄煤层滚筒采煤机综采工艺模式的方法
US10235622B2 (en) * 2017-01-24 2019-03-19 Sas Institute Inc. Pattern identifier system
WO2018146514A1 (en) * 2017-02-07 2018-08-16 Qatar University Generalized operational perceptrons: newgeneration artificial neural networks
US20180330059A1 (en) 2017-05-09 2018-11-15 James Stewart Bates Patient treatment systems and methods
US9922285B1 (en) * 2017-07-13 2018-03-20 HumanCode, Inc. Predictive assignments that relate to genetic information and leverage machine learning models
CN107742151A (zh) * 2017-08-30 2018-02-27 电子科技大学 一种中医脉象的神经网络模型训练方法
US20210065844A1 (en) * 2017-09-05 2021-03-04 Adaptive Phage Therapeutics, Inc. Methods to determine the sensitivity profile of a bacterial strain to a therapeutic composition
JP7453988B2 (ja) 2019-03-01 2024-03-21 サノフイ 治療の有効性を推定する方法
WO2022087540A1 (en) * 2020-10-23 2022-04-28 The Regents Of The University Of California Visible neural network framework
CN113077849B (zh) * 2021-03-16 2023-03-31 华南农业大学 一种大肠杆菌β-内酰胺类获得性耐药表型预测复合方法
CN113966999A (zh) * 2021-10-28 2022-01-25 中山大学 一种索拉非尼耐药性预测方法、装置及可存储介质
CN114726419A (zh) * 2022-04-07 2022-07-08 重庆邮电大学 基于深度学习的共轭梯度大规模mimo检测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5862304A (en) * 1990-05-21 1999-01-19 Board Of Regents, The University Of Texas System Method for predicting the future occurrence of clinically occult or non-existent medical conditions
SE504769C2 (sv) * 1994-03-17 1997-04-21 Agrovision Ab Sätt och anordning för automatisk bedömning av spannmål
JPH08110896A (ja) * 1994-10-10 1996-04-30 Nippondenso Co Ltd フィードフォワード型ニューラルネットワーク
AU1837495A (en) * 1994-10-13 1996-05-06 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
US5930154A (en) * 1995-01-17 1999-07-27 Intertech Ventures, Ltd. Computer-based system and methods for information storage, modeling and simulation of complex systems organized in discrete compartments in time and space
JP3786442B2 (ja) * 1995-01-23 2006-06-14 帝人株式会社 薬剤感受性予測方法
WO1997029447A2 (en) * 1996-02-09 1997-08-14 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
US5845049A (en) * 1996-03-27 1998-12-01 Board Of Regents, The University Of Texas System Neural network system with N-gram term weighting method for molecular sequence classification and motif identification
US5953727A (en) * 1996-10-10 1999-09-14 Incyte Pharmaceuticals, Inc. Project-based full-length biomolecular sequence database
US5945289A (en) * 1996-12-20 1999-08-31 Lehrer; Steven Method for detecting prostate cancer by apolipoprotein E (Apo-E) genotyping
US5860917A (en) * 1997-01-15 1999-01-19 Chiron Corporation Method and apparatus for predicting therapeutic outcomes
IL130635A0 (en) * 1997-01-17 2000-06-01 Maxygen Inc Evolution of whole cells and organisms by recursive sequence recombination
SE9702008D0 (sv) * 1997-05-28 1997-05-28 Pharmacia Biotech Ab A method and a system for nucleic acid seouence analysis
EP1012334A4 (de) * 1997-07-30 2004-12-29 Virologic Inc Zusammensetzungen und verfahren zur bestimmung von anti-viraler wirkstoff suszeptibilität und resistenz sowie anti-virales wirkstoff-screening
AU4691799A (en) * 1998-06-17 2000-01-05 Musc Foundation For Research Development Recognition of protein coding regions in genomic dna sequences

Also Published As

Publication number Publication date
EP1352356B1 (de) 2009-10-14
CA2415832C (en) 2012-07-24
AU6752001A (en) 2001-12-17
CA2415832A1 (en) 2001-12-13
US20030190603A1 (en) 2003-10-09
EP1352356A2 (de) 2003-10-15
WO2001095230A3 (en) 2003-08-21
ATE445883T1 (de) 2009-10-15
ES2334011T3 (es) 2010-03-04
JP2004523725A (ja) 2004-08-05
AU785353B2 (en) 2007-02-01
WO2001095230A2 (en) 2001-12-13
JP4726177B2 (ja) 2011-07-20

Similar Documents

Publication Publication Date Title
DE60140211D1 (de) Verfahren um die resistenz gegen ein therapeutisches agenz vorherzusagen unter verwendung neuronaler netze
Mahmud et al. Loss of the proprioception and touch sensation channel PIEZO2 in siblings with a progressive form of contractures
Klaus et al. What, if, and when to move: basal ganglia circuits and self-paced action initiation
Azaiez et al. TBC 1 D 24 Mutation Causes Autosomal‐Dominant Nonsyndromic Hearing Loss
Shea et al. Optimal release strategies for biological control agents: an application of stochastic dynamic programming to population management
Dawid et al. Object-oriented Bayesian networks for complex forensic DNA profiling problems
Zaidi et al. Facial masculinity does not appear to be a condition-dependent male ornament and does not reflect MHC heterozygosity in humans
DK0842475T3 (da) Computerunderstøttede fremgangsmåder og apparat til diagnosticering af sygdomme
Hübschmann et al. Analysis of mutational signatures with yet another package for signature analysis
Anand et al. Autosomal dominant SCN8A mutation with an unusually mild phenotype
CN104854617A (zh) 健康护理分析流的管理
BR9811441A (pt) Método de proteção para identificar indìviduos com risco de desenvolvimento de doenças associadas a diferentes formas polimórficas do p53 de tipo natural
DE60233203D1 (de) System zum bereitstellen von elektronischen kontaktinformationen aus einer zentralen quelle und verfahren zur aktualisierung der kontaktinformationen
KR101955568B1 (ko) 모바일 센서 데이터 기반 교통 약자 맞춤형 이동 경험조사 시스템 및 방법
Jamieson et al. The pain interactome: connecting pain-specific protein interactions
Elgoyhen et al. Identifying tinnitus‐related genes based on a side‐effect network analysis
DE60321689D1 (de) Systeme und verfahren zum schliessen auf biologische netzwerke
Kharazmi et al. Familial risk of pleural mesothelioma increased drastically in certain occupations: A nationwide prospective cohort study
Jerez et al. Bone metastasis modeling based on the interactions between the BMU and tumor cells
Gujer et al. A stochastic model of an ozonation reactor
Sato et al. Chromosome-scale assembly of wild barley accession “OUH602”
CN111883210A (zh) 基于临床特征和序列变异的单基因病名称推荐方法及系统
FR2869488B1 (fr) Procede et systeme d'elaboration d'une population representative d'un ensemble d'utilisateurs d'un reseau de communication
JP7002861B2 (ja) 地域包括ケア事業システム
KR20190067717A (ko) 부호화 기술을 이용한 기계학습 장치 및 시스템

Legal Events

Date Code Title Description
8364 No opposition during term of opposition